Mental disorders and termination of education in high-income and low and middle-income countries: Epidemiological study

S. Lee, A. Tsang, J. Breslau, Sergio Aguilar-Gaxiola, M. Angermeyer, G. Borges, E. Bromet, R. Bruffaerts, G. De Girolamo, J. Fayyad, O. Gureje, J. M. Haro, N. Kawakami, D. Levinson, M. A Oakley Browne, J. Ormel, J. Posada-Villa, D. R. Williams, R. C. Kessler

Research output: Contribution to journalArticlepeer-review

84 Scopus citations

Abstract

Background Studies of the impact of mental disorders on educational (OR=1.4) and impulse control disorders (OR=2.2) were attainment are rare in both high-income and low- and associated with early termination of secondary education. In middle-income (LAMI) countries. LAMI countries, impulse control disorders (OR=1.3) and substance use disorders (OR=1.5) were associated with early Aims . termination of secondary education. To examine the association between early-onset mental disorder and subsequent termination of education. Conclusions Onset of mental disorder and subsequent non-completion of Method education are consistently associated in both high-income Sixteen countries taking part in the World Health and LAMI countries. Organization World Mental Health Survey Initiative were surveyed with the Composite International Diagnostic Declaration of interest Interview (n=41 688). Survival models were used to estimate R.C.K. has been a consultant for GlaxoSmithKline, Kaiser associations between DSM-IV mental disorders and Permanente, Pfizer Inc, Sanofi-Aventis, Shire Pharmaceuticals subsequent non-attainment of educational milestones. and Wyeth-Ayerst; has served on advisory boards for Eli Lilly & Company and Wyeth-Ayerst; and has had research support Results for his epidemiological studies from Bristol-Myers Squibb, Eli In high-income countries, prior substance use disorders were Lilly & Company, GlaxoSmithKline, Johnson & Johnson associated with non-completion at all stages of education Pharmaceuticals, Ortho-McNeil Pharmaceutical mc, Pfizer Inc (OR 1.4-15.2). Anxiety disorders (OR=1.3), mood disorders and Sanofi-Aventis.

Original languageEnglish (US)
Pages (from-to)411-417
Number of pages7
JournalBritish Journal of Psychiatry
Volume194
Issue number5
DOIs
StatePublished - 2009

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Medicine(all)

Fingerprint Dive into the research topics of 'Mental disorders and termination of education in high-income and low and middle-income countries: Epidemiological study'. Together they form a unique fingerprint.

Cite this